Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbusinesswire.com
Business Wire Health: Clinical Trials News
Get the latest updates from Business Wire Health: Clinical Trials News directly as they happen.
Follow now 105 followers
Latest posts
Last updated about 3 hours ago
AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting
about 3 hours ago
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Presents Positive Preclinical Data on ABCL575 at...
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
about 5 hours ago
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an...
Arcus Biosciences Announces New Employment Inducement Grants
about 6 hours ago
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused...
Rocket Pharmaceuticals Announces Late-Breaking Oral Presentation of Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Accepted at 28th Annual Meeting of the American Society of Gene and Cell Therapy
about 6 hours ago
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology...
BeiGene annonce ses résultats financiers et ses mises à jour commerciales pour le premier trimestre de 2025
about 6 hours ago
SAN CARLOS, Californie--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ : ONC ; HKEX : 06160...
QuantHealth Unveils The Industry’s First Pharmaco-Clinical Foundation Model Focused on Clinical Applications of AI in Life Sciences
about 13 hours ago
NEW YORK--(BUSINESS WIRE)--QuantHealth, an AI-powered clinical trial simulation company, today unveiled its...
Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital
about 14 hours ago
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) (“bluebird”) today reminds all stockholders...
Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL
about 14 hours ago
FOSTER CITY, Calif.--(BUSINESS WIRE)---- $mirm #easl2025--Volixibat Data from Mirum’s VANTAGE PBC Study...
IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial
about 15 hours ago
WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the POTOMAC Phase III trial showed...
PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF)
about 15 hours ago
BOSTON--(BUSINESS WIRE)--PureTech Announces Publication of New Research Highlighting Untold Experiences of People...
LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis
about 16 hours ago
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart...
Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study
about 16 hours ago
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced 24-week post-end of...